Imhoff John E sold GTHP
March 6, 2025 · Form 4 insider transaction
Imhoff John E sold 300 shares of Guided Therapeutics, Inc., a transaction worth N/A. The trade was recorded as j and disclosed on an SEC Form 4.
Direction
Disposed (sell-side)
Shares
300
Price
N/A
Total value
N/A
InsiderImhoff John E
RoleDirector, 10% owner
SecurityPreferred Series D Stock
Transaction codeJ: J
Transaction dateMarch 6, 2025
Filing dateApril 17, 2025
Shares owned after0
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
On March 6, 2025, Mr. Imhoff converted 300 shares of Series D preferred stock into 900,000 shares of common stock. The Series D preferred stock had a stated value of $750 and $0.25 exercise price.